The process of evaluating medical technologies for third-party coverage.

Area of Science:

• Health Services Research
• Medical Technology Assessment
• Health Policy

Background:

• Coverage decisions by health insurance programs significantly impact medical technology diffusion and innovation.
• Understanding the processes used by payers like Medicare and private insurers is crucial for evaluating technology adoption.

Purpose of the Study:

• To compare the technology evaluation and coverage decision-making processes of the Medicare program and a major private health plan.
• To identify differences in methodologies, data utilization, and decision criteria between the two types of payers.

Main Methods:

• A detailed review of over 100 technology evaluations and associated coverage decisions from Medicare and a Blue Cross/blue Shield plan.
• Analysis of the types of information sources used (e.g., literature reviews, governmental agency recommendations, expert input) and their influence.

Main Results:

• Medicare evaluations were highly structured, relying on extensive literature reviews and expert recommendations, with limited influence from non-governmental sources.
• The private plan's evaluations were less structured, primarily based on advisory committee meetings with more limited informational inputs.
• Both carriers recommended coverage for slightly over 50% of evaluated technologies, with strong positive data on safety and effectiveness leading to near-certain coverage.

Conclusions:

• Significant differences exist in the payers' evaluation stages and their willingness to decide on coverage with tentative data.
• The speed and nature of technology assessment by payers can critically influence the adoption rate and innovation of new medical technologies.
• A clear understanding of these diverse technology assessment processes is essential for stakeholders in the healthcare industry.